RecruitingNot ApplicableNCT04678635

Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies


Sponsor

University of Sao Paulo

Enrollment

40 participants

Start Date

Dec 12, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria2

  • Classification criteria - EULAR/ACR 2017
  • Classification critera - Connors et al.

Exclusion Criteria6

  • Neoplasia
  • Using heart pacemarker
  • Using visceral metalic clips
  • Infections (HIV, HTLV-1, Hepatitis, etc)
  • Pregnance
  • Previous historical of convulsions or epilepsies

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERChronic transcranial direct current stimulation

Chronic transcranial direct current stimulation


Locations(1)

Samuel K Shinjo

São Paulo, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04678635


Related Trials